+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative study of phenothiazine derivatives on monoamine metabolism--direct correlation between the concentrations of drugs and monoamine metabolites in the brain



Comparative study of phenothiazine derivatives on monoamine metabolism--direct correlation between the concentrations of drugs and monoamine metabolites in the brain



Journal of Pharmacology and Experimental Therapeutics 240(3): 959-965



The pharmacokinetics (distribution and elimination) and pharmacodynamics (biochemical effects on monoamine systems) of phenothiazines including the novel compound, E-0663 (10-[3-(3-hydroxypyrrolidinyl)-propyl]-2-trifluoromethyl phenothiazine), in the central nervous system were investigated concurrently in mice using high-performance liquid chromatography with electrochemical detection. The elimination rate of E-0663 from the brain was longer than that of the classical compounds, chlorpromazine, perphenazine and triflupromazine. The phenothiazine (0.01-100 mumol/kg i.v.) increased the metabolites of catecholamines. Direct correlation analysis was applied to the intracerebral concentrations of the drugs and monoamine-related substances. Significant correlations were observed between the concentrations of drugs and dopamine metabolites (3,4-dihydroxyphenylacetic acid and homovanillic acid). The relative potency of the drugs for the effect on the extraneuronal process was promethazine less than chlorpromazine less than E-0663 less than triflupromazine less than perphenazine by covariance analysis. On the other hand, noradrenaline metabolite (3-methoxy-4-hydroxyphenylethylene glycol) also revealed a significant correlation, and the potency was highest in the case of E-0663. These results suggest that E-0663 possessed different pharmacokinetic profiles and a different spectrum in its action on monoamine metabolism from classical phenothiazines. The method described here is simple for comparing the real potency and is useful as a new approach in the biochemical pharmacology of centrally acting drugs.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039622816

Download citation: RISBibTeXText

PMID: 2882017


Related references

Phenothiazine derivatives and intracerebral monoamine metabolism: Application of direct correlation analysis between the levels of drugs and monoamine metabolites in rat brain. Nichidai Igaku Zasshi 53(9): 701-709, 1994

Intracerebral drug concentration and monoamine metabolism 3. a comparative study of phenothiazine derivatives. Japanese Journal of Pharmacology 36(SUPPL): 147P, 1984

Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction. Neuropatologia Polska 20(1-2): 97-105, 1982

Further studies on monoamine metabolism in three regions of mouse brain during pregnancy: monoamine metabolite concentrations and the effects of injected hormones. Archives Internationales de Pharmacodynamie et de Therapie 212(1): 48-59, 1974

Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease. Journal of Neural Transmission Parkinson's Disease and Dementia Section 5(3): 193-202, 1993

Influence of phenothiazine derivatives on the accumulation of brain amines induced by monoamine oxidase inhibitors. Biochem Pharmacol 11(10): 967-972, 1962

Effect of chronic caffeine administration on monoamine and monoamine metabolite concentrations in rat brain. Neuropharmacology 29(6): 599-602, 1990

Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. Clinical Neuropharmacology 10(4): 376-383, 1987

Regulation of the monoamine concentrations in the rat brain by intraneuronal monoamine oxidase. Biogenic Amines 6(1): 1-14, 1989

Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: Correlation with changes in monoamine-oxidase activity and monoamine levels. Neuropharmacology 37(7): 927-935, 1998

Effects of E2011, a novel inhibitor of monoamine oxidase type A, on monoamine metabolism in the rat brain. Japanese Journal of Pharmacology 67(SUPPL 1): 236P, 1995

Effects of transient global ischemia and a monoamine oxidase inhibitor ifenprodil on rat brain monoamine metabolism. Progress in Brain Research 106: 173-180, 1995

Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group. Acta Psychiatrica Scandinavica 53(1): 7-20, 1976

Evidence for release of brain amines by reserpine in presence of monoamine oxidase inhibitors: Implication of monoamine oxidase in norepinephrine metabolism in brain. Jour Pharmacol And Exptl Therap 130(3): 256-261, 1960

Antiepileptic drugs and monoamine metabolism in the brain. British Journal of Pharmacology 64(3): 407p, 1978